P C1952 takes positive steps toward updating Puerto Rican law to cover biologics and interchangeable biosimilars in a way that protects patients. Unlike traditional chemical drugs, biologics are unique, complex structures made from living cells that are not easily replicated. A small change or difference in the biosimilar or biologic manufacturing process has the potential to adversely impact the patient.

On July 24th, the Texas Pharmaceutical and Therapeutics (P&T) Committee, a part of the Texas Health and Human Services Commission, convened to review a number of different medications and medication classes for entry onto their Preferred Drug List (PDL) of the Texas Medicaid Formulary. A medication to alleviate symptoms of opioid-induced constipation (OIC) was one […]

On July 13th, the Global Healthy Living Foundation, working with the Coalition of State Rheumatology Organizations and the Arthritis Foundation, in cooperation with the Congressional Arthritis Caucus, co-hosted a congressional briefing on “Biosimilars for Arthritis Patients: Challenges and Opportunities.”

Dr. Neal Raisman, a GHLF advocate who lost his son Isaac to meningitis in 2005, provided testimony before the ACIP, urging the Committee to approve the meningitis B vaccine for routine clinical use.

Dear Mr. Ginsberg,

Thank you for your June 12, 2015, letter to Acting Commissioner Ostroff on behalf of the Global Healthy Living Foundation regarding the labeling of biosimilars. Your letter was forwarded to the Center for Drug Evaluation and Research for response.

The Global Healthy Living Foundation (GHLF) is a 501 (c)(3) patient group that works to improve the
quality of life for people with chronic disease, often focusing on those least able to advocate for
themselves. As a patient advocacy organization…

My name is Kathleen Hoffmann. I’m a patient advocate and member of the Global Healthy Living Foundation’s 50-State Network. I have been a resident of New Jersey for the last 33 years. I am currently in the process of…

The Global Healthy Living Foundation (GHLF) is a 501 (c)(3) patient advocacy organization
that works to improve the quality of life for people living with chronic …

My name is Candice Dusset. I’m a patient advocate and member of the Global Healthy Living Foundation’s 50 State Network.

Attached please find a comment letter concerning House Bill 319 which addresses the substitution of biologics and interchangeable biosimilars. We kindly request that you support this bill. We believe that HB 319 …